Genflow Biosciences plc (LON:GENF – Get Free Report) traded up 3.4% during mid-day trading on Thursday . The stock traded as high as GBX 1.99 and last traded at GBX 1.99. Approximately 2,461,160 shares were traded during trading, an increase of 13% from the average daily volume of 2,170,370 shares. The stock had previously closed at GBX 1.93.
Genflow Biosciences Stock Down 4.3%
The company has a fifty day simple moving average of GBX 2.07 and a 200-day simple moving average of GBX 2.06. The firm has a market cap of £10.78 million, a P/E ratio of -5.73 and a beta of 2.30.
Genflow Biosciences (LON:GENF – Get Free Report) last issued its earnings results on Thursday, April 30th. The company reported GBX (0.33) earnings per share (EPS) for the quarter. Genflow Biosciences had a negative net margin of 170.64% and a positive return on equity of 332.06%.
Genflow Biosciences Company Profile
Genflow Biosciences plc is a UK based biotech company with R&D facilities in Belgium and a US office in Cambridge, MA, driven by one mission: to deliver therapeutics that potentially halt or slow the ageing process in humans and dogs.
The company’s lead compound works through the delivery of a centenarian variant of the SIRT6 gene and has yielded promising preclinical results.
Featured Articles
- Five stocks we like better than Genflow Biosciences
- Defense Earnings Show Readiness Now and Modernization Ahead
- Why Palantir Investors Aren’t Panicking While the Rest of AI Sells Off
- MarketBeat Week in Review – 07/20- 07/24
- AMD and Cerbras Create A New Blueprint For Hardware
Receive News & Ratings for Genflow Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genflow Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.
